Borregaard Borregaard’s Capital Markets Day (CMD) will take place today at Oslo Concert Hall, starting at 09:00 and ending at 12:30 CEST. The event can be followed via webcast (https://www.borregaard.com/investors/ir-news/capital-markets-day-2024/). The written material supporting the presentations is enclosed. Key highlights - Borregaard CMD 2024: The specialisation journey continues BioSolutions – diversified portfolio attractively positioned for growth BioMaterials – focus on regulated applications in tightening markets Organic growth – top priority with market-driven innovation portfolio Bio-based start-ups – leveraging expert knowledge, investing for the long term Solid financial platform for accelerated growth During the presentation, the President and CEO, Per A. Sørlie, will provide an update on key strategic considerations and the company’s strategic priorities. The executive vice presidents in BioSolutions and Speciality Cellulose will give market updates focusing on attractive growth opportunities driven by sustainability and regulatory trends. The SVP R&D and Business development will elaborate on innovation, organic growth and bio-based investments. The CFO, Per Bjarne Lyngstad, will comment on financial performance and Borregaard being positioned for accelerated growth. Borregaard ASA Sarpsborg, 18 September 2024 Contact: Lotte Kvinlaug, Investor Relations Officer, +47 922 86 909 This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act. Attachment Borregaard Capital Markets Day 2024
Borregaard ASA: Borregaard’s Capital Markets Day – The dawn of specialisation
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...